The Long COVID Treatment Trial (LoCITT, pronounced lock-it) is a novel research platform funded by the Schmidt Initiative for Long Covid (SILC) as part of its grant to support the tirzepatide trial
This triple action may reduce appetite, increase fullness, support blood sugar control and influence how the body uses energy
Another important finding is that several bacterial genera with anti-inflammatory functions, such as Faecalibacterium , Bifidobacterium , and Roseburia , are decreased in the group of ME/CFS patients [21]
Armed with this insight, you and your PlexusDx provider can select the most likely effective medicationwhether that's higher-dose semaglutide, tirzepatide, or a dual-compound approachand restart your weight loss momentum
Before researchers knew of Ozempics ability to reduce alcohol cravings, patients were already reporting a reduction in food and alcohol consumption